| Financial Year |
March 31 2023 |
| Monetary Funds |
2,357,468,063.19 |
| Held-for-trading Financial Assets |
222,970,783.57 |
| Notes Receivable |
832,931,760.96 |
| Accounts Receivable |
2,066,025,996.78 |
| Advances to Suppliers |
53,545,575.40 |
| Other Receivables |
31,773,899.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,681,667,759.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
218,918,288.49 |
| Total Current Assets |
8,160,009,021.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
182,400,200.02 |
| Investment Properties |
43,989,299.46 |
| Fixed Assetes |
3,405,250,132.85 |
| Under-construction Projects |
1,362,157,512.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
337,826,947.36 |
| R&D expenses |
-- |
| Goodwill |
421,831,593.46 |
| Long-Term Deferred and Prepaid Expenses |
190,805,253.07 |
| Deferred Income Tax Assets |
89,510,487.12 |
| Other Non-Current Assets |
83,157,087.44 |
| Sub-Total of Non-Current Assets |
6,989,528,617.32 |
| Total Assets |
15,149,537,639.20 |
| Short-Term Loans |
157,596,526.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,162,278,226.39 |
| Accounts Payable |
2,127,591,876.56 |
| Accounts Received In Advance |
1,339,057.16 |
| Employee Compensation Payable |
145,192,901.02 |
| Taxes Payable |
79,457,988.56 |
| Interest Payable |
-- |
| Dividend Payable |
15,646.07 |
| Other payables |
478,158,179.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
247,471,375.77 |
| Other Current Liabilities |
81,962,192.23 |
| Sub-Total of Current Liabilities |
5,629,290,639.66 |
| Long-term Loans |
516,211,979.02 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,615,770.46 |
| Deferred Income Tax Liabilities |
203,863,377.75 |
| Other Non-Current Liabilities |
511.50 |
| Sub-Total of Non-Current Liabilities |
829,770,658.33 |
| Total Liabilities |
6,459,061,297.99 |
| Paid-In Capital(Or Share Stock) |
1,361,994,647.00 |
| Capital Surplus |
7,245,971.54 |
| Surplus Reserve |
91,359,027.15 |
| LESS:Treasury Stock |
82,165,144.15 |
| Undistributed Profits |
3,362,712,121.95 |
| Minority Stockholder's Interest |
3,452,731,124.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,237,745,216.74 |
| Owner's Equity（Stockholder's Equity） |
8,690,476,341.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,149,537,639.20 |
